Canagliflozin: INH

Name : Canagliflozin
Synonym : (1S)-1,5-Anhydro-1-C-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl}-4-methylphenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-{3-[5-[4-Fluoro-phenyl)-thiophen-2-ylmethyl]-4-methyl-phenyl}-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol; Anagliflozin
Mol Formula : C24H25FO5S
CAS : 842133-18-0
Functions : 1. Pharmaceuticals>Diabetes>Hyperglycemia>

Progress Life Sciences Pvt. Ltd.(PLS) Canagliflozin: INH is a professionally managed rapidly evolving company founded by technocrats with a vision to carry out business globally. This company has been founded by 1st generation enterprenuers with a strong desire to create a world class generic pharmaceutical and chemical company Canagliflozin: INH. At PLS, we believe that success is defined by the positive impact which we make on the world around us. Since the beginning, our goal has always been to provide access to affordable healthcare solutions to millions of people who are in need.
We are a lean company with skilled,educated & experienced professionals who look after various critical operations on day to day basis and have been successfully able to establish the base for a bigger business platform globally. Our present core focus area remains APIs and intermediates Canagliflozin: INH.
Over a period of time PLS has successfully been able to develop new products, gained market approvals, made commercial supplies to customers of reupte in both domestic and international markets & have created a basket which will bring in growh for the company and its people. Our Products are being exported to LATAM, Middle East and Asian subcontinents.
We plan to venture into formulation and finished dosage business and are open for new ideas for collaborations & believe in co-creation of breakthrough solutions.
Progress curently holds Good manufacturing practices (GMP) license issued by food and drug administration Pune – in accredition to the practices being followed to manufacture the goods therein.
Common side effects include vaginal yeast infections, nausea, constipation, and urinary tract infections.[2] Serious side effects may include low blood sugar, Fournier’s gangrene, leg amputation, kidney problems, high blood potassium, and low blood pressure.[2] Diabetic ketoacidosis may occur despite nearly normal blood sugar levels.[2] Use in pregnancy and breastfeeding is not recommended.[1] Canagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor.[2] It works by increasing the amount of glucose lost in the urine


There are no reviews yet.

Be the first to review “Canagliflozin: INH”

Your email address will not be published. Required fields are marked *